chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Caller is a nurse reporting a temperature excursion, requesting stability data; This spontaneous report was received from a nurse referring to a patient of unknown age and gender.      On 21-OCT-2020, the patient was vaccinated with one dose of improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) (lot number was T009929, expiration date was 16-SEP-2021, strength and route were not reported) for prophylaxis (improper storage of product in use).     Temperature excursion of this vaccine was -6.6 degrees Celsius for 1 hour and 45 minutes without any previous temperature excursion. The digital data logger was involved. This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2010USA010348: US-009507513-2010USA010299: US-009507513-2010USA010518: US-009507513-2010USA010508: US-009507513-2010USA010598: US-009507513-2010USA010384: US-009507513-2010USA010735: US-009507513-2010USA010299: US-009507513-2010USA010348: US-009507513-2010USA010526: US-009507513-2010USA010709:
nose bleeds 4 days in a row, prolonged 90 minutes, recurrent, bilateral nostrils
Shingles  started 10 pm 2/3/21 at 10 pm Virtual office visit 2/4/21 at 12:45 pm.  Valacyclovir HCl 1 Gmail tid prescribed
Blood tinged stools the day of vaccines & sporadically thereafter x10 days.  Baby feeling well with 14.7 wt gain in 10 days.  Likely perianal fissure on exam.
This spontaneous report as received from a nurse refers to an unspecified number of patients of unknown age and gender. On an unknown date the patients were vaccinated with improperly stored dosed of VARIVAX (Merck). (strength, route, lot number and expiration date not reported). No adverse effects reported. This is one of two reports received from the same reporter (1409USA003408). Additional information has been requested.
Cannot walk because feet are impacted by ulcers; Allergic reactions because delayed response of immune system; This spontaneous case was reported by a patient and describes the occurrence of GAIT DISTURBANCE (Cannot walk because feet are impacted by ulcers) and HYPERSENSITIVITY (Allergic reactions because delayed response of immune system) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 058F214, 006B21A and 004M20A) for COVID-19 vaccination.     Concurrent medical conditions included Allergic reaction to antibiotics (Doxycycline, Augmentin) and Drug allergy (Lisinopril). Concomitant products included AZILSARTAN KAMEDOXOMIL (EDARBI), HYDROCHLOROTHIAZIDE, ATORVASTATIN and VITAMIN D NOS for an unknown indication.   On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Aug-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced GAIT DISTURBANCE (Cannot walk because feet are impacted by ulcers) and HYPERSENSITIVITY (Allergic reactions because delayed response of immune system). The patient was treated with TACROLIMUS (topical) at a dose of 1 % percent (Tacrolimus 1%). At the time of the report, GAIT DISTURBANCE (Cannot walk because feet are impacted by ulcers) and HYPERSENSITIVITY (Allergic reactions because delayed response of immune system) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2022, Laboratory test: concomitant medication were not causing symptoms..         Patient not tested positive to Covid-19. Patient states that patient also had a body rash a couple of months ago.  The doctors also did test to know if the concomitant medication might be causing these symptoms and proved they were not causing them. As treatment some other medications were also used, but the patient did not know the names of these.   This case was linked to MOD-2022-636334 (Patient Link).
no temp, reddness & swelling rt thigh where MMR was given; inject given 28SEP92; seen by MD on 29SEP92; MD placed on DPH & Ibuprofen;
Sudden onset severe diarrhea, accompanied by nausea (no vomiting), chills, severe fatigue, and diffuse rash over LE initially, then to UE. No rash on trunk. Diarrhea resoled in 4 hours after 3 doses of Imodium. Remained afebrile.  Benadryl 25mg taken that night, and the next night as rash continued to be itchy.
pt recv vax 1MAR97 & approx 13MAY98 pt exp numerous black-outs & fainting spells which resulted in hosp for 9 days;sx similar to those of MS;pt becomes fatigued quickly, has to use walker @ times uses a wheelchair;also undergoing PT;Annual follow-up received on 11/27/00 provided no additional data.
Patient fainted within minutes of receiving Hep. A and HPV vaccine. Lasted a few seconds. Placed patient on floor with legs elevated while she sipped on sweet tea.
Pt recv vax on unknown date; on 8/19/98 pt exp large swelling at vax site & urticaria; 8/26/98 pt imp.
I did not see it but the patient describes initially discomfort, itching and redness below the injection site and then arm swelling that progressed down to the fingers.  There was pain initially but that improved before the swelling progressed down the arm.  (I spoke to him on 3/3 about the symptoms - the pain was gone - swelling continued)
clotting; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE 1, MANUFACTURER UNKNOWN), for COVID-19 immunization; Covid-19 vaccine (DOSE 2, MANUFACTURER UNKNOWN), for COVID-19 immunization. The following information was reported: THROMBOSIS (medically significant), outcome "unknown", described as "clotting".  Clinical information: The caller had called in regards to the Pfizer booster shot. The caller had called on behalf of caller's wife, the patient. The caller did have lot numbers for the product and wanted to know if there had been any adverse events on the lot numbers for issues because patient was clotting and patient had never clotted before. Wanted to know if these boosters could have caused the clotting. Called the other day for patients first 2 shots with the lot numbers. The caller had called now because the caller wanted to report on booster now and see if there were any issues.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
right sided facial tingling after receiving his first vaccination/ numbness and tingling lasted approx. 3 days; right sided facial tingling after receiving his first vaccination/ numbness and tingling lasted approx. 3 days; This is a spontaneous report from a non-contactable other healthcare professional. A 38-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot/batch number not reported), via an unspecified route of administration in right deltoid muscle on an unspecified date at a single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, patient was seen at the COVID Vaccine Clinic today for his second dose of the COVID 19 vaccination (Lot number: EK9231). He denied any history of previous adverse reactions to other vaccines but does note he had tingling to the right side of his face after his first dose that lasted 3 days. He was given the Pfizer vaccination in the right deltoid muscle. During his 15 minute waiting period after the injection, the patient began to experience tingling to right side of face. Patient states he had right sided facial tingling after receiving his first vaccination but was not evaluated in the medical bay. He states the numbness and tingling lasted approx. 3 days. Denied weakness in right sided facial muscles at that time. Stable to go home and follow up with PCP. The outcome of the events was recovered.   No follow-up attempts are possible; information regarding lot/batch number cannot be obtained. No further information is expected.
Patient returned to the pharmacy on 7/26/18 at 10:30AM with a swollen arm and red arm that was warm to touch. The reaction was similar to that of a bee sting. I asked her how she was feeling, and she stated she felt a lot of soreness in the arm as well as weakness. I used a cold pack to help alleviate the soreness in her arm and instructed her to take diphenhydramine when she gets home, and to contact EMS if she her condition gets worse.
Hives/itchiness mon upper chest, R arm&leg , self resolved in 15 min
Patient received Johnson and Johnson vaccine at age 17 (underage since it is for 18 and older).  Patient reported feeling a little feverish and had body aches later that night after receiving the vaccine.  The symptoms only lasted that day and the patient fully recovered the next day.
1505: Received vaccine 1506: C/o headache, throat tingling "like when I have a reaction to shellfish." B/P 138/90 1508: 100mg po liquid Benadryl given 1512: tongue hurts, BP 118/80, HR 80 1518: c/o sensation moving to the front of her mouth, 0.5mg IM Epinephrine given 1528: EMS called, pt brought to local ER, discharge home from ER.
sudden  nausea, lightheadedness, passed out, severe chills, all over body aches;  lasted several hours; recovered at home
Low grade temperature of 101.2 dealt with by taking aspirins. Overall body ache dealt with by aspirins. Extreme pain in area of left arm/shoulder where the vaccine was given. Arm severely ached for 48 hours in any position, was very tender/painful to touch, and difficult to use or move. I'm pretty tough where pain is concerned with past injuries (broken leg in 17 pieces, severely sprained ankles, broken ribs, broken tail bone from horse accident. This vaccination arm pain was right up there with the worst.
Patient came in with his fiancé for their 2nd dose of the moderna. I administered the patient with his second shot of the moderna, then he sat on the chair in the waiting area after his vaccine. I then gave his fiancé her 2nd shot of the moderna. As I was done giving the shot, his fiancé and I noticed his eyes are rolling backwards and he started to faint in the chair.  Then his wife and I tried to waking him. He regained conscience after 20 seconds or more. He was extremely hot so I got him a water.  I had him wait 10 minutes after so I can monitor him.
Pain and redness at injection site. Wheezing, chills, can?t get warm.
Low grade fever, chills, body aches, extreme fatigue every 28 days (it?s happened three times already)
Patient called back after a few weeks of getting the shot and said that he had some pain in his left arm at the injection site and it sometimes radiates into the neck area. We advised some counseling treatments and followed up with patient twice within a weeks time frame. He mentioned he was doing a little better on 12/31/2020. Patient then called back a few weeks later and mentioned his arm was still hurting.
Chronic Headache for 3.5 weeks.  No history of headaches.  Three subsequent doctors visits to assess.
Diaphoresis, flushing, some facial swelling, some mild pruritus at site of injection
Pt recv vax on 4/10/98; 15 min post vax pt exp warm feeling & scratchy throat
Face is swole up around her eyes/ describes the sweling as water bags under the eyes; This a spontaneous report from two contactable consumers. This female consumer (patient) and her son reported. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in left arm on 02Feb2021 at 17:30 as 1ST dose, single for covid-19 immunization. Patient medical history and concomitant medications were not reported. On an unspecified the patient experienced face was swollen up around her eyes, no difficulty breathing. Swelling was worse on the right side of her face, but she received the shot in her left arm. She described the swelling as "water bags under the eyes". She also reported having had a flu shot about 3 weeks ago. She was concerned about the side effects and the second dose. Swelling of face can be a sign of severe allergic reaction but would typically occur within the first hour. It was reported that patient might had a mild, delayed allergic response. The patient was also referred back to HCPs for treatment / to have a plan for the second dose and let vaccinator know about the reaction when she goes for the second dose. Outcome of the event was unknown.  Information about Lot/Batch number is requested.  Follow-up attempts are completed. No further information is expected.
Hives - jaw and neck 2 1/2 hours after given no other symptoms noted. Given 50 mg BENADRYL.
Pressure in eyes; Pressure in head; Severe chills; Headache; Dizziness; Blurred vision; Feeling very cold; Weakness; Could not sleep all night; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 14Apr2021 at 10:00 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19.Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 23Mar2021 at 10:00 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. On 14Apr2021 at 17:00, the patient experienced pressure in eyes and head, severe chills, headache, dizziness, blurred vision, feeling very cold, weakness and could not sleep all night. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events pressure in eyes and head, severe chills, headache, dizziness, blurred vision, feeling very cold, weakness and could not sleep all night was resolved on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
This spontaneous report was received from a registered nurse regarding a female patient of unknown age. On 24-JUL-2009, the patient was vaccinated with dose 1 of GARDASIL (lot#, route and dose not reported). No concomitant medications were reported. On 03-AUG-2012, the patient received the second dose of GARDASIL (lot#, route and dose not reported). No adverse effects were reported. The patient was in the office today to receive the third dose. It was unspecified if the patient had sought medical attention. Additional information has been requested.
This is a spontaneous report from a contactable Certified Nurse Practitioner via Pfizer sales representative. A patient of unspecified age ethnicity and gender received PREVNAR 13, via an unspecified route of administration on an unspecified date, within the last 6 months, at single dose for immunisation. The patient medical history and concomitant medications were not reported. The patient experienced a low platelet count (non serious) after receiving vaccine. The outcome of the event was unknown. The information on the batch/lot number has been requested.
Very fast onset of debilitating arthritis of the wrists and hands which continued to advance to other larger joints, such as hips, shoulders and knees. Pain was intense and mobility was severely restricted for over six months.
pt recvd vax & exp pain in left hip, leg & foot, fatigue & loss of motor control in head & neck after vax;
I had joint pain that I hadn't had before.  It was in all my joints.  It started to get worse in late June/early July.  I had been working out and had to stop.  I made an appointment to see my doctor and was supposed to see her on September 13, but the appointment was cancelled and I rescheduled for Friday September 24th.
This spontaneous report as received from a Certified Medical Assistant (CMA) refers to an unspecified number of patients of unknown age and gender. Medical history and concurrent conditions were not provided. On an unknown dates, the patients were vaccinated with an improperly stored doses of GARDASIL (dose, route, lot number and expiry date were not reported). No adverse effects reported or product quality complaints (PQC) involved. There was no concomitant medication provided. This is one of several reports received from the same reporter. Additional information has been requested.
Fever of 104 F; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever of 104 F) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-May-2021, the patient experienced PYREXIA (Fever of 104 F). At the time of the report, PYREXIA (Fever of 104 F) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medications were provided No treatment medications were provided   Reporter did not allow further contact
Lips, tingling, throat feeling swollen, feels like a lump is in her throat and a headache. Symptoms started 30 min to a hour after injection. Patient took OTC Benadryl and Tylenol. Symptoms improved.
Severe body aches and joint pain in entire body.   Received my shot 2 weeks ago and still have the same severe pain.
Vaccine exposure during pregnancy; Vaccination site pain; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) and VACCINATION SITE PAIN (Vaccination site pain) in a 67-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 027A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 06-Feb-2021, the patient experienced VACCINATION SITE PAIN (Vaccination site pain). On an unknown date, the patient experienced EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). At the time of the report, EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) had resolved and VACCINATION SITE PAIN (Vaccination site pain) outcome was unknown.            The patient received both scheduled doses of mRNA-1273 prior to the events, therefore action taken with the drug in response to the events was not applicable.  Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Patient started having a brief loss of consciousness around a few minutes after the vaccination was given. Observed shortness of breath, drop in temperature from 97.1 to 94.2 within 15 minutes, temporary loss of vision, nausea, dizziness and lightheadedness. Informed patient to sit up-right and to sit on the bench and frequently talked to the patient in order to keep them conscious until paramedics arrived. Patient had slowly recovered after around 30-45 minutes and left with the paramedics.
Jynneos administered intramuscularly; Case reference number US-BN-2022-001696 is a spontaneous case report initially received on 27-Jul-2022 from a health care professional via agency (reference number: USBAV22-0690) and concerns a *44-years-old male patient*.  The patient's medical history and concomitant medication details were not reported.  On *13-Jul-2022*, the patient was vaccinated with the first dose of Jynneos (Smallpox and Monkeypox Vaccine, Live, Nonreplicating, batch number: FDP00002), intramuscularly (IM), at a dose of 0.5 mL, at the *left deltoid* for pre-exposure prophylaxis (PrEP) (explicitly coded as Inappropriate route of vaccination'). As reported, the patient worked in a lab that handled monkeypox samples.   At the time of this report, it was known that the patient did not experience any adverse events due to Jynneos vaccination.  This case is linked with case no. US-BN-2022-001673, US-BN-2022-001687, US-BN-2022-001688, US-BN-2022-001689, US-BN-2022-001690, US-BN-2022-001691, US-BN-2022-001692, US-BN-2022-001693, US-BN-2022-001694, US-BN-2022-001695, US-BN-2022-001697, US-BN-2022-001698, US-BN-2022-001699, US-BN-2022-001700, US-BN-2022-001701, concerning the same reporter.  Non-significant case correction received from Bavarian Nordic on 29-Jul-2022 included an additional reference number.  All follow-up information is blended into the case narrative above, with the latest information presented between asterisks (*). Follow-up information received from a healthcare professional via Bavarian Nordic on 09-Aug-2022 included patient details and additional information about the administrated dose of Jynneos.; Reporter's Comments: A 44-year-old male patient was vaccinated with the first dose of Jynneos, intramuscularly, at dose of 0.5 mL, at the left deltoid, for pre-exposure prophylaxis which is considered as inappropriate route of vaccination. Incorrect route of product administration is considered listed per company convention. At this point, it was known that the patient did not experience any adverse event due to Jynneos vaccination. The patient's medical history and concomitant medication details were not reported. Causality is assessed as not related to suspect product but to human factor. The case is non-serious.; Sender's Comments: A 44-year-old male patient was vaccinated with the first dose of Jynneos, intramuscularly, at dose of 0.5 mL, at the left deltoid, for pre-exposure prophylaxis which is considered as inappropriate route of vaccination. Incorrect route of product administration is considered listed per company convention. At this point, it was known that the patient did not experience any adverse event due to Jynneos vaccination. The patient's medical history and concomitant medication details were not reported. Causality is assessed as not related to suspect product but to human factor. The case is non-serious.